Researcher Database

（Last updated : 2024-11-05 12:46:34）　

SOEDA SHUHEI

Department / Course College of Pharmaceutical Sciences Department of Pharmacy

Title / Position Assistant Professor

Academic background
1.	2013/09 Degree Acquisition	│ Graduate School of Medical and Pharmaceutical Sciences Doctor of Philosophy (Medicinal Sciences)
2.	～2013/09	Doctoral Program (2nd Semester) │ Graduate School of Medical and Pharmaceutical Sciences │ Graduate School of Chiba University │ Completed
3.	2009/03 Degree Acquisition	│ Graduate School of Pharmaceutical Sciences　of Showa University Master of pharmaceutical sciences degree
4.	～2009/03	Doctoral Program (1st Semester) │ Pharmaceutical Sciences │ Graduate School of Pharmaceutical Sciences │ Graduate School of Showa University │ Completed
5.	～2003/04	Department of Pharmaceutical Sciences │ Faculty of Pharmaceutical Sciences │ Hokuriku University │ Graduated

Business career
1.	2017/04/01 ～	Assistant Professor │ College of Pharmaceutical Sciences, │ Ritsumeikan University

Research activities
1.		The Japanese Biochemical Society
2.		The Pharmaceutical Society of Japan

Qualification and license
1.	2007	License to practice pharmacy

Subject of research
1.	Function analysis of genes related to differentiation and development

Present specialized field
Neurochemistry/ Neuropharmacology, Genome biology, Molecular biology, Cell biology, Biological pharmacy (Keyword：Pharmaceutical Sciences, Molecular Cell Biology, Necdin, MAGE family, Prader Willi, Neuron, Differentiation, Development)

Papers
1.	2024/08/20	Pathological analysis of Prader-Willi syndrome using adipocytes │ Biochem. Biophys. Res. Commun. │ 721 (Co-authored)
2.	2024/03/06	Role of plant homeodomain finger protein 8 in P19 embryonic carcinoma cells revealed by genome editing and specific inhibitor │ Biochemistry and Biophysics Reports │ 38 (Co-authored)
3.	2023/06/25	Defects in early synaptic formation and neuronal function in Prader-Willi syndrome │ Scientific Reports │ 13 (Co-authored)
4.	2023/09/01	v-Src delocalizes Aurora B by suppressing Aurora B kinase activity during monopolar cytokinesis │ Cellular Signalling │ 109 (Co-authored)
5.	2021/04/26	Abnormal DNA methylation in pluripotent stem cells from a patient with Prader-Willi syndrome results in neuronal differentiation defects │ Stem Cell Research │ 53-102361 (Co-authored)
Display All（17）

Message
1.	Why we study about rare disease Prader-Willi syndrome? Laboratory member said the laboratory which we belong does not attract new students. This reason is we study rear disease and the laboratory inferior to laboratories which study cancer, diabetes, and Alzheimer-type dementia. I accepted this idea and could not say No. Because I took public offering of position of associated researcher,So, I did not know Prader-Willi syndrome(PWS). Then, I thought again whether it has purpose and benefit. In conclusion, the first of this idea, it has a few competition of researcher. For example, it needs much effort, results, and time to be authority of cancer research, but, it has possibility to be authority of PWS with publishing few papers. Second, in fact, there are patients of rear disease PWS. It has problems that there are few researchers for rear disease, and slow progression of the study, so that it is hard to find the therapy. So, we think that we have to approach these problems. Even if there are few patients in the world, they need study of rear diseases.　Someone who is interested in our work, please contact us. It will produce new idea and discovery to collaborate with other fields researchers and other disease studies.